Fundraising Fox
Cassidy Blundell
InvestorPartner at Mission Biocapital · Board director at Progentos Therapeutics · Board director at Mediar Therapeutics
Cambridge
Writes $500K checks · typically $1.5M
Find your path to Cassidy
187 people in our graph share verified history with Cassidy — schools, employers, funds. One of them is your warm intro.
Rathi SrinivasunlockedCassidy: together at Firefly BioWorks (2011)
×11Cassidy: together at Mission Biocapital
About
Partner in the Cambridge office focused on therapeutics investments and company building; board director at Progentos, Mediar, Volnay, and ARase, and board observer at Vaxess. Joined as an analyst in 2018. Holds a PhD in Bioengineering from the University of Pennsylvania.
Contact· self-published, not guessed
Invests in
AgTechBiotechFoodTechHealthtechMedical DevicesNew Materials
Board director at Progentos Therapeutics
Intro paths
→
In turn, Cassidy can intro founders to Progentos Therapeutics's investors below.
Board director at Mediar Therapeutics
Intro paths
→
In turn, Cassidy can intro founders to Mediar Therapeutics's investors below.
Mediar Therapeutics's investors · 11
Agent CapitalWalthamAmplitude Venture CapitalMontreal · since 2026GimvAntwerp · $20M – $400M checksLongwood FundBoston · since 2026Mission BiocapitalSan Francisco · $500K checks · since 2025Novartis Venture FundBasel · $5M – $25M checks · since 2022Ono Venture Investment, Inc.South San FranciscoPfizer Venture Investments$5M – $20M checksPfizer VenturesShangBay Capital LLCPalo AltoSofinnova PartnersParis · $540K – $27M checks · since 2025
Experience
- Mission BioCapitalPartnercurrent2024 — presentCambridge, Massachusetts, United States
- Mission BioCapitalPrincipal2021 — 2024
- Mission BioCapitalAssociate2019 — 2021
- Mission BioCapitalAnalyst2018 — 2019
- University of PennsylvaniaBioengineering PhD Student2012 — 2018Philadelphia, Pennsylvania, United States
- Flagship PioneeringVentureLabs Fellow2017Cambridge, Massachusetts, United States
- Firefly BioworksBioassay Scientist2011
Skills & more
Immunofluorescence3Biomedical Engineering7Cell Culture2Microfluidics1Research4SolidWorks1Matlab1LabVIEWPolymerase Chain Reaction (PCR)MicroscopyMicrosoft Excel1Data Analysis1
+1 more
Molecular BiologyFrom Cassidy's professional profile.
Investments
Board seats
Per SEC Form D filings.
What founders say
No founder feedback on Cassidy Blundell yet.
Colleagues at Mission Biocapital
Chaya Patel
Principal at Mission Biocapital
Chris Carlin
Chief Operations Officer and Chief Compliance Officer at Mission Biocapital
Clay Rowland
Investment Associate at Mission Biocapital
Douglas Crawford
Managing General Partner at Mission Biocapital
Jennifer Griffin
Partner at Mission Biocapital
Johannes Fruehauf
General Partner at Mission Biocapital
Josephine Brysting
Investment Analyst at Mission Biocapital
Linda Eng
Director of Operations, Bay Area at Mission Biocapital
Network5
Chaya Patel
Principal at Mission Biocapital
Douglas Crawford
Managing General Partner at Mission Biocapital
Helen Siaw
Analyst at Mission Biocapital
Jennifer Griffin
Partner at Mission Biocapital
Johannes Fruehauf
General Partner at Mission Biocapital
Investors connected to Cassidy in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Cassidy Blundell?
- Partner in the Cambridge office focused on therapeutics investments and company building; board director at Progentos, Mediar, Volnay, and ARase, and board observer at Vaxess. Joined as an analyst in 2018. Holds a PhD in Bioengineering from the University of Pennsylvania.
- Where does Cassidy Blundell work?
- Cassidy Blundell is Partner at Mission Biocapital and Board director at Progentos Therapeutics and Board director at Mediar Therapeutics.
- What does Cassidy Blundell invest in?
- Cassidy Blundell invests in AgTech, Biotech, FoodTech, Healthtech, Medical Devices, New Materials.
- What check size does Cassidy Blundell write?
- Cassidy Blundell typically writes checks of $500K.
- What boards does Cassidy Blundell sit on?
- Cassidy Blundell holds tracked board seats at Mediar Therapeutics, Progentos Therapeutics.
- Where did Cassidy Blundell go to school?
- Cassidy Blundell studied at University of Pennsylvania (Doctor of Philosophy (PhD), Bioengineering); Boston University (B.S., Biomedical Engineering).
Same school
Also attended University of Pennsylvania1,432
Brian ActonCo-founder of WhatsApp; co-founder of Signal FoundationKunal BahlCo-founder of Snapdeal; co-founder of Titan CapitalDasha MaggioPartner at Felicis Ventures, writer on venture capital and founder psychologyLeah von SiemensPartner at Manta Ray VenturesEghosa OmoiguiFounder and Managing General Partner at EchoVC PartnersAkshat GoenkaInvestor at Moonfire Ventures
+ 1,426 more
Shared employers
Also worked at Mission BioCapital15
Robert BlazejPartner at Mission BiocapitalMark ByrnesDirector of Operations, Cambridge at Mission BiocapitalZach CollinsPartner at Mission BiocapitalDouglas CrawfordManaging General Partner at Mission BiocapitalJohannes FruehaufGeneral Partner at Mission BiocapitalSamar JahanVice President of Finance at Mission Biocapital
+ 9 more
Also worked at University of Pennsylvania211
Wesley BarrowPartner at Correlation VenturesDavid MagermanManaging Partner at Differential VenturesVyas RamananVenture Partner at Third Rock VenturesLouis BernemanFounding Partner at Osage University PartnersBrian HalakManaging Partner at Medical Excellence CapitalDiana BernsteinDirector at Northpond Ventures
+ 205 more
Also worked at Flagship Pioneering107
Anika GuptaInvestor at GV (Google Ventures)Noubar AfeyanInvestor at Flagship PioneeringDavid KoleskyPrincipal at MPM BioImpactDiana BernsteinDirector at Northpond VenturesInca ComanVenture Partner at ARCH Venture PartnersAndrew BrochuController at Castle Island Ventures
+ 101 more